MAP2K7 and B-cell chronic lymphocytic leukemia: Fourthly, in vitro activation of BCR signaling by anti-IgM BCR antibodies induced activation of both MEK/ERK and PI3K/AKT signaling in CLL, thereby protecting CLL cells from apoptosis [4, 28].